Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Brownsville, Texas 16 trials found
New Search
Filter
Trial Phase
Study Type
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
PHASE4INTERVENTIONAL Brownsville, Texas
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
PHASE3INTERVENTIONAL Sacramento, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type